Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Weinstein

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Emerging Infectious Diseases|September 24, 2016
Locally Acquired Eastern Equine Encephalitis Virus Disease, Arkansas, USAJeremy Garlick, T Jacob Lee, Patrick Shepherd, et al.
MMWR. Morbidity and Mortality Weekly Report|October 27, 2017
Notes from the Field: High Volume of Lyme Disease Laboratory Reporting in a Low-Incidence State - Arkansas, 2015-2016Natalie A Kwit, Elizabeth A Dietrich, Christina Nelson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2009
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancerRobert E Roses, E Carter Paulson, Anupama Sharma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancerGary K Koski, Ursula Koldovsky, Shuwen Xu, et al.
Cancer|January 19, 2012
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situAnupama Sharma, Ursula Koldovsky, Shuwen Xu, et al.
American Journal of Surgery|October 6, 2009
Asymptomatic changes in cardiac function can occur in ductal carcinoma-in-situ patients following treatment with HER-2/neu-pulsed dendritic cell vaccinesSusan Bahl, Robert E Roses, Anupama Sharma, et al.
MMWR. Morbidity and Mortality Weekly Report|July 6, 2018
Chagas Disease Surveillance Activities - Seven States, 2017Carolyne Bennett, Anne Straily, Dirk Haselow, et al.
Clinical Breast Cancer|July 16, 2008
Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancerJulia Tchou, Joel Greshock, Meredith R Bergey, et al.
MMWR. Morbidity and Mortality Weekly Report|February 9, 2018
Potential Confounding of Diagnosis of Rabies in Patients with Recent Receipt of Intravenous Immune GlobulinNeil M Vora, Lillian A Orciari, J Bradford Bertumen, et al.
Cancer Research|February 13, 2007
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretionBrian J Czerniecki, Gary K Koski, Ursula Koldovsky, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Emerging Infectious Diseases|September 24, 2016
Locally Acquired Eastern Equine Encephalitis Virus Disease, Arkansas, USAJeremy Garlick, T Jacob Lee, Patrick Shepherd, et al.
MMWR. Morbidity and Mortality Weekly Report|October 27, 2017
Notes from the Field: High Volume of Lyme Disease Laboratory Reporting in a Low-Incidence State - Arkansas, 2015-2016Natalie A Kwit, Elizabeth A Dietrich, Christina Nelson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2009
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancerRobert E Roses, E Carter Paulson, Anupama Sharma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancerGary K Koski, Ursula Koldovsky, Shuwen Xu, et al.
Cancer|January 19, 2012
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situAnupama Sharma, Ursula Koldovsky, Shuwen Xu, et al.
American Journal of Surgery|October 6, 2009
Asymptomatic changes in cardiac function can occur in ductal carcinoma-in-situ patients following treatment with HER-2/neu-pulsed dendritic cell vaccinesSusan Bahl, Robert E Roses, Anupama Sharma, et al.
MMWR. Morbidity and Mortality Weekly Report|July 6, 2018
Chagas Disease Surveillance Activities - Seven States, 2017Carolyne Bennett, Anne Straily, Dirk Haselow, et al.
Clinical Breast Cancer|July 16, 2008
Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancerJulia Tchou, Joel Greshock, Meredith R Bergey, et al.
MMWR. Morbidity and Mortality Weekly Report|February 9, 2018
Potential Confounding of Diagnosis of Rabies in Patients with Recent Receipt of Intravenous Immune GlobulinNeil M Vora, Lillian A Orciari, J Bradford Bertumen, et al.
Cancer Research|February 13, 2007
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretionBrian J Czerniecki, Gary K Koski, Ursula Koldovsky, et al.
Pageof 3